BeOne Medicines

688235

Current ValuationThe current P/E ratio is 91.38, above the reasonable range, cheaper than 16.86% of the time in the past 3 years, and the industry ranks 31/84, the industry Median 21.22.

91.38xP/E
Stock price¥253.69Earnings per share¥2.78

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 21.22x
0255075100

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 21.22x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
688235SHBeOne Medicines
91.38x245.86%¥391.26B
688796SHBiocytogen
99.32x--¥36.90B
301080SZACROBIOSYSTEMS
84.73x38.72%¥16.50B
600201SHJINYU
96.46x147.87%¥13.87B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.